@article{880ff9f261444368a7bccc7f2eefffbe,
title = "Glycolate oxidase inhibition by lumasiran varies between patients with primary hyperoxaluria type 1",
keywords = "hyperoxaluria, lumasiran, pediatric nephrology, stable isotopes",
author = "Garrelfs, {Sander F.} and Metry, {Elisabeth L.} and {van Harskamp}, Dewi and Vaz, {Frederic M.} and {van den Akker}, {Chris H.P.} and Groothoff, {Jaap W.} and Oosterveld, {Michiel J.S.} and Henk Schierbeek",
note = "Funding Information: The authors thank all the patients with primary hyperoxaluria type 1 for their participation. This work was funded by the Amsterdam UMC ; personal PhD scholarship for SFG; Alnylam Pharmaceuticals (unconditional grant); and Metakids (grant 2019-04-UMD).",
year = "2023",
month = may,
doi = "https://doi.org/10.1016/j.kint.2023.01.029",
language = "English",
volume = "103",
pages = "990--993",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",
}